NeoGenomics Reports Revenue of $63.1 Million on 17% Volume Growth and 11% Reduction in Average Cost per Test in the Third Quarter of 2017
Press Release
Read More
NeoGenomics Announces Preliminary Quarter 3 Results, Financial Impacts of Hurricanes and Summary Quarter 4 Guidance
Press Release
Read More
CD49d Expression in Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma: A Reference Laboratory Perspective
Literature
Read More
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy
Literature
Read More
Prevalence of somatic mutations in patients with aplastic anemia using peripheral blood cfDNA as compared with BM
Literature
Read More
NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017
Press Release
Read More